2018 Annual Meeting

Pre-Conference


CIS, along with AMLI, will once again be offering the Update on Diagnostic Advances in Primary Immunodeficiencies on Thursday, April 26, prior to the start of the 2018 Annual Meeting. This pre-conference will provide an intellectual forum for attendees to discuss the latest in diagnostic advances in the field if immune regulation and dysregulation.
 

2018 Pre-Conference Final Program


 

Annual Meeting Program

The 2018 Annual Meeting Final Program is now available. Click below to access.
 

2018 Annual Meeting Final Program

 

All plenary sessions will take place in Grand West and Centre at the Sheraton Centre. All exhibits and poster sessions will be in the Sheraton Hall/Osgoode Ballroom.
 

Networking & Additional Education Sessions

Open AllClose All
  Thursday, April 26

7:00 am – 2:00pm
Update on Diagnostic Advances in Primary Immunodeficiencies Pre-Conference
(Separate Registration Required)
 

2:30pm – 2:40pm
Welcome from CIS President

Roshini Abraham, PhD

Mayo Clinic

 

2:40pm - 4:00pm
CIS Fellowship Grantee Presentations

1.5 AMA PRA Category 1 Credits™

 

Moderators:
Roshini Abraham, PhD
Mayo Clinic

Shanmuganathan Chandrakasan, MD
Emory University School of Medicine
Children's Healthcare of Atlanta

 

Speaker:
Site-Specific Gene Therapy In The Treatment Of X-Linked Hyper-IgM Syndrome
Caroline Kuo, MD
University of California, Los Angeles


Oral Abstracts:
Conditioning with anti-CD45 immunotoxin in a mouse model of hypomorphic Rag1 deficiency allows complete reconstitution of the immune system with lack of toxicity            
Enrica Calzoni, MD
Laboratory of Clinical Immunology and Microbiology, DIR, NIAID, NIH, DHHS


PTCRA mutations yield novel T cell immune deficiency 
Sarah Henrickson, MD, PhD
The Children's Hospital of Philadelphia

 

DIAGNOSIS AND PRE-TRANSPLANT MANAGEMENT OF SCID PATIENTS IN THE ERA OF NEWBORN SCREENING: A SURVEY OF PRACTICES IN THE PRIMARY IMMUNE DEFICIENCY TREATMENT CONSORTIUM
Jennifer R. Heimall, MD
Children’s Hospital of Philadelphia

 

4:00pm - 6:00pm
Plenary Session: Patient Management: Controversies in PIDs

2 AMA PRA Category 1 Credits™


Moderators:
Steve Holland, MD, National Institute of Allergy and Infectious Disease, NIH
Troy Torgerson, MD, PhD, University of Washington & Seattle Children's Research Institute

Panelists:
Jack Routes, MD
Medical College of Wisconsin

Alexandra Freeman, MD
National Institute of Health

Donald Vinh, MD
McGill University Health Centre

Klaus Warnatz, MD
Medical Center, University of Freiburg

Elie Haddad, MD, PhD
CHU Ste-Justine, University of Montreal

Lisa Forbes, MD
Baylor College of Medicine

Catharina Schuetz, MD
Ulm University Medical Center, Pediatrics, Germany

 

6:00pm - 7:00pm
Robert A. Good Lecture

1 AMA PRA Category 1 Credits™


Moderator:

Troy Torgerson, MD, PhD
University of Washington & Seattle Children's Research Institute


Speaker:
Genetic Immunodeficiencies and Bone Marrow Failure
Akiko Shimamura, MD, PhD
Dana Farber/Boston Children's Cancer and Blood Disorders Center

  Friday, April 27

7:00 am - 8:00 am: Breakfast

7:00 am - 8:00 am
Genomics 101 A
*SESSION FULL*
Elgin--Second Floor

  • Isabelle Meyts, MD, Leuven University, Belgium
  • Asbjorg Stray-Pedersen, MD, PhD, Oslo University Hospital, Norway
     

7:00 am - 8:00 am
Genomics 101 B
*SESSION FULL*

Peel--Mezzanine Level

  • Ivan Chinn, MD, Baylor College of Medicine
  • Janet Chou, MD, Children’s Hospital of Boston

 

8:00am - 9:30am
Plenary Session: Cross-Talk: PIDs from the Perspective of Other Specialties

1.5 AMA PRA Category 1 Credits™


Moderators:

Elena Hsieh, MD, University of Colorado


Speakers:
Very Early Onset Inflammatory Bowel Disease (VEOIBD): Novel Genes, Novel Diseases, Novel Therapies
Aleixo Muise, MD, PhD
Sick Kids Toronto

When It Rains, It Pours - Tumor Predisposition in PID and Vice Versa
Markus Seidel, MD
Medical University Graz

Brain on Fire: Inflammatory Brain Disease in Immune Dysregulations
Susanne Benseler, MD
Alberta Children’s Hospital, Calgary

All That Rashes Is Not Eczema: Deciphering Dermatologic Clues of PID in the Itchy Red Child
Markus Boos, MD, PhD
Seattle Children’s Hospital

 

Oral Abstract:
Clinical, imaging, and pathology features of cytotoxic T-lymphocyte antigen 4 haploinsufficiency associated neuroinflammation   
Matthew Schindler, MD
National Institute of Neurological Disorders and Stroke


9:30am - 9:45am: Morning Break

9:45am - 11:30am
Plenary Session: The Thymus: Understanding the Biology, Diseases, and Treatment

2 AMA PRA Category 1 Credits™

 

Moderators:

Stuart Turvey, MBBS, DPhil, FRCPC, University of British Columbia

Joyce Yu, MD, Morgan Stanley Children's Hospital/Columbia University Medical Center

 

Speakers:
Fixing To Regenerate Human T-Lymphopoiesis
Juan Carlos Zúñiga-Pflücker, PhD
Sunnybrook Research Institute, Canada

Mechanisms That Regulate Pathways in Intrathymic T-cell Development
Graham Anderson, PhD
University of Birmingham, UK

Thymus Transplant and Update on Thymus Transplant Task Force
Mary Louise Markert, MD, PhD
Duke University School of Medicine

Oral Abstract:
RAG1 HYPOMORPHIC MOUSE MUTANTS SHOW PARTIAL PRESERVATION OF THYMOCYTE DEVELOPMENT BUT PECULIAR ABNORMALITIES OF THYMIC EPITHELIAL CELL PHENOTYPE
Marita Bosticardo, PhD
NIAID, NIH

 

11:30am - 1:00pm
Lunch/Exhibit Hall/Poster Hall Open

Sheraton Hall/Osgoode Ballroom

 

11:30am - 12:30pm
WCIS Luncheon

Grand East

12:00 pm - 12:20 pm     
Lightning Poster Presentations

Osgoode Ballroom

 

Moderators:
Roshini Abraham, PhD, Mayo Clinic
Troy Torgerson, MD, PhD, University of Washington & Seattle Children’s Research Institute

 

PARACOCCIDIOIDOMYCOSIS ASSOCIATED WITH A HETEROZYGOUS STAT4 MUTATION AND IMPAIRED IFN-Γ IMMUNITY
Antonio Condino-Neto, MD, PhD, University of São Paulo

 

ALTERNATIONS IN REPERTOIRE OF T AND B CELL SUBSETS IN PATIENTS WITH PARTIAL RECOMBINATION ACTIVATING GENE (RAG) DEFICIENCY WITH AUTOIMMUNITY AND HISTORY OF VIRAL INFECTIONS    
Krisztian Csomos, PhD, University of South Florida

 

A CELL BASED ASSAY FOR THE DETECTION OF AUTOANTIBODIES TO IL-17 IN HUMAN SERUM
Matt Phillips, PhD, National Jewish Health

 

CHROMOSOME 22Q11.2 DELETION SIZE AFFECTS PERIPHERAL LYMPHOCYTE SUBSET COUNTS    
Melanie Ruffner, MD, PhD, Children's Hospital of Philadelphia

 

PROFOUND B CELL LYMPHOPENIA IN GOF-STAT1 THAT IMPROVES POST RUXOLITINIB    
Tara Saco, MD, University of South Florida


12:20 pm - 1:00 pm     
Poster Viewing

Sheraton Hall/Osgoode Ballroom

1:00 pm - 1:30 pm     
CIS Business Meeting


1:30pm - 3:00pm
Plenary Session: Immune Complications Caused by Therapeutic Intervention

1.5 AMA PRA Category 1 Credits™


Moderators:

James Chipeta, BSc., MBChB, PhD, University of Zambia

Monica Lawrence, MD, University of Virginia
 

Speakers:
B Cell Depleting Immunotherapies: Complications and Opportunities
Thomas Tedder, PhD, Duke School of Medicine


Immune Dysregulation Following the Use of Checkpoint Inhibitors for Malignancies
Maria Suarez-Almazor, MD, PhD
MD Anderson Cancer Center

Immune Defects and Complications Following CAR-T Cell Therapies
Kevin Curran, MD
Memorial Sloan Kettering Cancer Center

Fontan and T Cell Lymphopenia
Jen Heimall, MD
Children's Hospital of Philadelphia

Oral Abstract:
VEDOLIZUMAB FOR AUTOIMMUNE ENTEROPATHY IN PRIMARY IMMUNODEFICIENCY: A CASE SERIES OF OUTCOMES   
Travis Sifers, MD
Icahn School of Medicine at Mount Sinai



3:00pm - 3:15pm: Afternoon Break

3:15pm - 4:15pm
Plenary Session:
Mining Patient Registries: USIDNET and Beyond
1 AMA PRA Category 1 Credits™
*Sponsored by USIDNET*


Moderators:
Kathleen Sullivan, MD, PhD
Children's Hospital of Philadelphia
Charlotte Cunningham-Rundles, MD, PHD
Mt. Sinai Medical Center

 

Speaker:
TBD
Nizar Mahlaoui, MD, MSc, MPH
French National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker Enfants Malades Hospital, University Paris Descartes, France

 

Oral Abstracts:

PROPHYLACTIC ANTIBIOTICS VS. IMMUNOGLOBULIN REPLACEMENT IN PATIENTS WITH SPECIFIC ANTIBODY DEFICIENCY
Joud Hajjar, MD
Baylor College of Medicine   

 

IMPACT OF PULMONARY COMPLICATIONS ON QUALITY OF LIFE IN THE USIDNET REGISTRY    
Kaileen Rohr, MD
Columbia University Medical Center

 

NEUROLOGIC COMPLICATIONS OF COMMON VARIABLE IMMUNODEFICIENCY: FINDINGS FROM THE USIDNET REGISTRY
Jenna Nguyen, MD
University of California-San Francisco


4:15pm - 4:30pm: Break

4:30pm - 5:30pm
Plenary Session:
CIS Rose/Fahey Founders Lecture

1 AMA PRA Category 1 Credits™

Moderator:

Megan Cooper, MD, PhD, Washington University in St. Louis


Speaker:
Tracking the Anti-Donor Alloresponse in Transplant Patients
Megan Sykes, MD
Columbia Center for Translational Immunology


5:30pm - 6:00pm
Plenary Session:
PID Year in Review

Article: "X-linked carriers of chronic granulomatous disease: Illness, lyonization, and stability" Journal of Allergy and Clinical Immunology, Volume 141, Issue 1, 365 - 371
Presenter: Kelli Williams, MD, MPH, Medical University of South Carolina
Mentor: Alexandra Freeman, MD, NIH

 

Article: "BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency." Nat Immunol. 2017 Jul;18(7):813-823. doi: 10.1038/ni.3753.
Presenter: Hey Chong, MD, PhD, University of Pittsburgh Children's Hospital
Mentor: Isabelle Meyts, MD, PhD, University Hospitals Leuven

 

Article: "Effective “activated PI3Kδ syndrome”–targeted therapy with the PI3Kδ inhibitor leniolisib." Blood Nov 2017, 130 (21) 2307-2316; DOI: 10.1182/blood-2017-08-801191
Presenter: Nicholas Hartog, MD, Helen DeVos Children's Hospital and Spectrum Health Medical Group
Mentor: Nicola Wright, MD, Alberta Children's Hospital

 

Article: "Long-term follow up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study." J Allergy Clin Immunol. 2017 Dec 11. pii: S0091-6749(17)31893-6. doi: 10.1016/j.jaci.2017.10.041
Presenter: Kiran Patel, MD, Emory University
Mentor: Magda Carneiro-Sampaio, MD, PhD, Universidade De Sao Paulo

 

Article: “Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase." J Allergy Clin Immunol 140(4): 1054-1067 e1010
Presenter: Joud Hajjar, MD, Baylor College of Medicine
Mentor: Thomas Isskeutz, MD, Dalhousie University

  Saturday, April 28

7:00 am - 8:00 am: Breakfast

7:00 am - 8:00 am: Breakfast Symposium: Exploring the Immunologic Basis for CGD and Implications for Clinical Practice

*Sponsored by Horizon Pharma*

7:00 am - 8:00 am
Flow 101 A
*SESSION FULL*
Elgin--Second Floor

  • Troy Torgerson, MD, PhD, University of Washington
  • David Hagin, MD, Tel-Aviv Sourasky Medical Center, Israel


7:00 am - 8:00 am
Flow 101 B *SESSION FULL*
Peel--Mezzanine Level

  • Michael Keeney, London Health Sciences Center (Ontario)
  • James Verbsky, MD, PhD, Medical College of Wisconsin


8:00 am - 9:50 am    
Plenary Session: Novel Insights and Approaches to Regulating Immunity

2 AMA PRA Category 1 Credits™


Moderators:

Sarah Henrickson, MD, PhD, Children's Hospital of Philadelphia

Manish Butte, MD, PhD, UCLA


Speakers:
New Treatments for Interferonopathies
Yanick Crow, BMedSci, MBBS, MRCP, PhD
University of Manchester, UK

Tailoring Thymic Tregs for Cellular Therapy
Megan Levings, PhD
BC Children's Hospital Research Institute, Canada

New Insights in Treg Biology in Human Health and Disease
Ciriaco A. Piccirillo, MD
McGill University, Canada

Early-onset immune dysregulation and targeted therapies
Kaan Boztug, MD
University of Vienna

Ustekinumab in Treating Complications of LAD
Steve Holland, MD
National Institute of Allergy and Infectious Disease, NIH

 

Oral Abstract:
FOXP3 GENE TRANSFER IN T CELLS AND FOXP3 GENE EDITING IN HSC AS NOVEL TREATMENT OPTIONS FOR IPEX SYNDROME    
Rosa Bacchetta, MD
Stanford University School of Medicine



9:50 am - 10:10 am: Morning Break

10:10 am - 11:40 am     
Plenary Session: Transplantation: From Bone Marrow to Solid Organ

1.5 AMA PRA Category 1 Credits™

 

Moderators:

Hélène Decaluwe, MD, PhD, FRCPC, CHU Sainte-Justine and University of Montreal  

Eyal Grunebaum, MD, Hospital for Sick Children

 

Speakers:
PIDTC Year in Review

  • Elie Haddad, MD, PhD, CHU Ste-Justine, University of Montreal
  • Elizabeth Kang, MD, National Institute of Allergy and Infectious Disease, NIH
  • Morton Cowan, MD, UCSF Benioff Children's Hospital

 

SOT/HCT Combined Transplantation
Paul Szabolcs, MD
Children's Hospital of Pittsburgh

 

Oral Abstracts:
ABERRANT T CELL ACTIVATION AND EXHAUSTION DEVELOPS IN POORLY RECONSTITUTED SCID SURVIVORS AFTER TRANSPLANT AND CORRELATES WITH THE ABSENCE OF CONDITIONING REGIMEN: A PRIMARY IMMUNE DEFICIENCY TREATMENT CONSORTIUM (PIDTC) STUDY

Hélène Decaluwe, MD, PhD, FRCPC
CHU Sainte-Justine and University of Montreal   

 

LATIN-AMERICAN CONSENSUS ON THE MANAGEMENT OF PATIENTS WITH SEVERE COMBINED IMMUNODEFICIENCY, PART 1: “SUPPORTIVE MEASURES DURING THE TIME FROM DIAGNOSIS TO DEFINITIVE TREATMENT.”    
Juan Carlos Bustamante Ogando, MD
National Institute of Pediatrics    


11:40 am -12:00 pm     
Plenary: Patient Advocacy Groups Update

.5 AMA PRA Category 1 Credits™

12:00 am - 2:00 pm     
Lunch/Exhibit Hall Open

Sheraton Hall/Osgoode Ballroom

1:00 pm - 1:20 pm     
Lightning Poster Presentations

Osgoode East Ballroom


Moderators:
Roshini Abraham, PhD, Mayo Clinic
Troy Torgerson, MD, PhD, University of Washington & Seattle Children’s Research Institute

 

IGG4-RELATED DISEASE (IGG4-RD), ITS COMMON MIMICKERS AND RESPONSE TO ANTI-IL5-(RESLIZUMAB) TREATMENT
Rachel Eisenberg, MD, Montefiore Medical Center

 

NOVEL NLRC4 GAIN-OF-FUNCTION MUTATION PRESENTING WITH NEONATAL ENTEROCOLITIS AND AUTOINFLAMMATION, WITH POSITIVE CLINICAL RESPONSE TO RAPAMYCIN AND ANAKINRA    
Annaliesse Blincoe, BHB, MBChB, CHU Sainte-Justine

 

MOLECULAR CHARACTERISATION OF CHRONIC GRANULOMATOUS DISEASE (CGD) PATIENTS IN A COHORT OF INDIA    
Manasi Kulkarni, MSc, National Institute Of Immunohaematology

 

IMMUNE -DYSREGULATION MIMICKING SYSTEMIC LUPUS ERYTHEMATOSUS IN A PATIENT WITH LYSINURIC PROTEIN INTOLERANCE    
Maria Cecilia Poli, MD, Baylor College of Medicine

 

IKBKB SEVERE COMBINED IMMUNODEFICIENCY: CLINICAL AND IMMUNOLOGIC PHENOTYPE AND STEM CELL TRANSPLANT OUTCOMES     
Tamar Rubin, MD, FRCPC, University of Manitoba


1:20 pm - 2:00 pm     
Poster Viewing

Sheraton Hall/Osgoode Ballroom

2:00 pm - 3:30 pm     
Plenary: Tales from the Listserv

1.5 AMA PRA Category 1 Credits™

 

Moderators:

  • Eric Allenspach, MD, PhD
    University of Washington & Seattle Children's Hospital
  • Elie Haddad, MD, PhD
    CHU Ste-Justine, University of Montreal
  • Mikko Seppänen, MD, PhD
    Helsinki University Central Hospital

Mystery Case #1
Jennifer Leiding, MD, University of South Florida

 

Mystery Case #2
Donald C. Vinh, MD, McGill University Health Centre


Mystery Case #3
David Buchbinder, MD, MS, Children’s Hospital of Orange County


3:30 pm - 4:00 pm: Afternoon Break

4:00 pm - 5:00 pm     

Plenary: Richard Schiff Lecture
1 AMA PRA Category 1 Credits™
*Sponsored by Shire*


Moderator:
Jack Routes, MD, Medical College of Wisconsin

 

Speaker:
Unraveling Graft-Versus-Host Disease Pathogenesis to Develop New Treatments
Bruce Blazar, MD
University of Minnesota


5:00 pm - 5:30pm     
Presidential Award Lecture
.5 AMA PRA Category 1 Credits™
 

Moderator:

Roshini Abraham, PhD, Mayo Clinic

 

Speaker:
Immune Dysregulation In T Cell Immunodeficiencies: Insights From The Analysis Of Repertoire Diversity And Composition
Luigi Notarangelo, MD
NIH


5:30 pm - 7:00 pm     
Closing Reception

Sheraton Hall/Osgoode Ballroom

  Sunday, April 29

7:00 am - 8:00 am: Breakfast

8:00 am - 10:30 am    
Plenary Session: Hot New Defects in Primary Immunodeficiencies

2.5 AMA PRA Category 1 Credits™

Moderators:

Andrew Cant, MD, Newcastle General Hospital

Lahari Rampur, MD, University of Washington Medical Center, Seattle

 

Speakers:
New Autoinflammatory Defects
Ivona Aksentijevich, MD
National Institutes of Health

Novel neomorphic gain-of-function autoinflammatory disease activating non-canonical inflammasome
Helka Goos, MD
University of Helsinki

TLR7 Deficiency
Eric Meffre, PhD
Yale University

 

Oral Abstract:
HUMAN PI3KGAMMA DEFICIENCY WITH HUMORAL DEFECTS AND LYMPHOCYTIC INFILTRATION OF BARRIER TISSUES    
Carrie Lucas, PhD
Yale University

 

IL2RB deficiency results in early-onset lymphoproliferation, multisystem autoimmunity, and pervasive CMV infection
Elena Hsieh, MD, University of Colorado, Denver

 

Dominant negative IKZF1 mutations cause a novel combined immunodeficiency
Hye Sun Kuehn, PhD, NIH

 

 

Abstracts

All notifications for submitted abstracts have been sent out. If you submitted an abstract, but have not seen your notification please check your spam/junk email. Questions can be directed to Sarah Tulley at stulley@clinimmsoc.org

 

Abstracts selected for poster presentation will have their poster number assigned at the end of the month.

Registration Fees


On-site registration will be available if you are unable to register online anytime before March 30, 2018.


ALL 101 SESSIONS ARE FULL. If you would like to be added to the waitlist please email Sarah Tulley at stulley@clinimmsoc.org.

Pre-Conference Advance Registration
(Feb. 9 - March 30)
Update on PID Only $300
Update on PID Discount with Annual Meeting $250
Annual Meeting Advance Registration
(Feb. 9 - March 30)
CIS Regular Member $550
CIS Trainee Member $250
CIS Associate / Allied Health Member $250
Non-Member $750
Non-Member: Trainee $300
Non-Member: Allied Health $400
Industry / Sponsor / Exhibitor $350
Developing Country (Member or Non-Member) $250
One Day Registration (Member or Non-Member) $300
101 Session $15

Register Now

Register for the 2018 CIS Annual Meeting to ensure your spot at the preeminent North American conference dedicated to immune deficiency and dysregulation. The 2018 Annual Meeting will feature the latest in clinical and basic science research. This is your chance to hear and learn from experts from around the globe speak on the latest in immune deficiency and dysregulation.

 

Get Started

Hotel Information

The room block at the Sheraton Centre is sold out. Rooms are still available at the Sheraton Centre but at a higher rate. Click here to go directly to the Sheraton Centre site to make a reservation.

 

HOTELS NEAR THE SHERATON CENTRE:

The following are a list of hotels that are near the Sheraton Centre that may have rooms available during the conference. Please contact the hotels directly to book a room. CIS does not have rooms blocked off at any of the hotels listed below.



Sheraton Centre Toronto
123 Queen Street West
Toronto, ON, M5H 2M9, Canada
Ph: 416.361.1000

About the Sheraton Centre Toronto
Located in the heart of Downtown Toronto, the Sheraton Centre is close to the city's top attractions, including the Hockey Hall of Fame, the CN Tower, Casa Loma and the Royal Ontario Museum, as well as providing attendees with access to world class shopping, dining and entertainment. We look forward to seeing you in Toronto!

Canada Travel Information

ALL VISITORS

To visit Canada, all travelers will need to meet some basic requirements:

  • Have a valid travel document, like a passport
  • Be in good health
  • Have no criminal or immigration-related convictions
  • Be able to explain to an immigration officer that you have ties—such as a job, home, financial assets or family—that will take you back to your home country
  • Explain to an immigration officer that you will leave Canada at the end of your visit
  • Have enough money for your stay (The amount of money you will need depends on how long you will stay and if you will stay in a hotel, or with friends or relatives).

ENTERING FROM THE UNITED STATES
  • The Canada Border Services Agency (CBSA) recommends that all US citizens carry a valid passport. A passport may be required by your airline or transportation authority.
  • If you are a United States citizen, be sure to carry proof of citizenship, such as a passport, along with photo identification. If you are a permanent U.S. resident, carry proof of your status such as a U.S. Permanent Resident Card.

ENTERING FROM NON-US COUNTRIES
  • All non-US visitors to Canada will be required to obtain either an Electronic Travel Authorization (eTA) or a visa for the length of their stay. Click below to determine which travel document you will
     

Do You Need an eTA or a Visitor Visa?

Exhibitors and Sponsors

The deadline to reserve a booth at the 2018 Annual Meeting has passed. To view the exhibit hall map or order materials for your booth please click the links to the right.

 

Exhibit Hall Hours:
  • Friday, April 27: 11:30am - 1:00pm
  • Saturday, April 28: 12:00pm - 2:00pm
                                        5:30pm - 7:30pm

 

Deadlines for Exhibitors:
  • March 9: Logo and Company Description Due
  • March 30: Exhibitor Registrations Due
  • April 24: Inserts due at the Sheraton Centre for inclusion in Annual Meeting Registration Bags. Click here for shipping instructions.


If you have any questions, please contact Sarah Tulley at stulley@clinimmsoc.org 

Poster Presentation Information

Poster Board Assignments

All posters have been assigned a board number for the poster hall. Click below to access the poster assignments; the listing is in alphabetical order by first name. We have tried to group posters, who share the same author, together. However, due to requests for the placement of Lightning Posters and Special Mention Posters, it was not always possible. If you have posters in multiple spots, please feel free to choose which poster to present during the times below.
 

POSTER ASSIGNMENTS

 

Poster Dimensions and Hanging

Posters may be hung Thursday, April 26 or the morning of Friday, April 27. All posters must be up before 11:30am on Friday, April 27th.

 

We have no requirements on what should be included on your poster, but please include all information you believe is of value to attendees.

 

Poster boards have a maximum space of  91”/2.3 meters wide x 45”/1.1 meter high.

 

Poster Session Times and Location

All poster sessions will be held in the Osgoode Ballroom/Sheraton Hall. All poster presenters are asked to be at their posters at the following times:

  • Friday, April 27: 12:20pm - 1:00pm
  • Saturday, April 28: 1:20pm - 2:00pm

 

Any questions regarding your poster or the poster session should be directed to Sarah Tulley, stulley@clinimmsoc.org.

 

top